| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 08/18/2021 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.69, valued at
$102.7k
|
|
| 01/06/2021 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 2,629 options to buy
@ $17.93, valued at
$47.1k
|
|
| 10/27/2020 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.52, valued at
$101.4k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $10.67, valued at
$64.8k
|
|
| 06/06/2018 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $11.54, valued at
$70.1k
|
|
| 02/13/2018 |
4
| Deshpande Milind (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 640,000 options to buy
@ $2.9, valued at
$1.9M
|
|
| 11/01/2017 |
3
| Deshpande Milind (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2016 |
4
| Deshpande Milind (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 400,000 options to buy
@ $7.61, valued at
$3M
|
|
| 01/23/2015 |
4
| Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 100,000 shares
@ $15, valued at
$1.5M
Exercised 100,000 options to buy
@ $3.02, valued at
$302k
|
|
| 12/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/19/2014 |
4
| Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 16,250 shares
@ $10, valued at
$162.5k
Sold 15,950 shares
@ $10, valued at
$159.5k
Sold 60,000 shares
@ $10, valued at
$600k
Sold 124,424 shares
@ $10, valued at
$1.2M
Exercised 16,250 options to buy
@ $4, valued at
$65k
Exercised 15,950 options to buy
@ $1.05, valued at
$16.7k
Exercised 60,000 options to buy
@ $3.28, valued at
$196.8k
Exercised 124,424 options to buy
@ $3.1, valued at
$385.7k
|
|
| 05/23/2014 |
4
| Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed of 250,000 options to buy
@ $3.02, valued at
$755k
Granted 250,000 options to buy
@ $3.02, valued at
$755k
|
|
| 12/19/2013 |
4
| Deshpande Milind (President and CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 400,000 options to buy
@ $3.02, valued at
$1.2M
|
|
| 05/30/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2012 |
4
| Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 5,312 shares
@ $10.7, valued at
$56.8k
Exercised 5,312 options to buy
@ $1.05, valued at
$5.6k
|
|
| 01/11/2012 |
4
| Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 10,625 shares
@ $9.34, valued at
$99.2k
Exercised 10,625 options to buy
@ $1.05, valued at
$11.2k
|
|
| 12/14/2011 |
4
| Deshpande Milind (President of R&D and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $7.59, valued at
$759k
|
|
| 06/24/2011 |
4
| Deshpande Milind (President and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 10,800 shares
@ $7.5063, valued at
$81.1k
Sold 4,825 shares
@ $7.5034, valued at
$36.2k
|
|
| 12/20/2010 |
4
| Deshpande Milind (President of R&D and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $3.1, valued at
$620k
|
|
| 12/22/2009 |
4
| Deshpande Milind (EVP and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 60,000 options to buy
@ $3.28, valued at
$196.8k
|
|
| 12/17/2008 |
4
| Deshpande Milind (EVP and CSO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC |